EPISODE · Jun 11, 2008 · 12 MIN
Does ApoB Trump Non-HDL Measurements?
from Lipid Luminations
Host: Larry Kaskel, MD Guest: Allan Sniderman, MD Consensus is building around apolipoprotein B (apoB) as the preferred tool for gauging the effectiveness of LDL-lowering therapies. Is it accurate, reproducible and cost-effective? Host Dr. Larry Kaskel welcomes Dr. Allan Sniderman, professor of cardiology at the McGill University Health Centre in Montreal, for a noteworthy discussion about apoB and its impact on our approach to atherogenic risk management. Will this test soon become standard in a lipid panel? Brought to you by:
Embed this episode
NOW PLAYING
Does ApoB Trump Non-HDL Measurements?
No transcript for this episode yet
Similar Episodes
No similar episodes found.